Search

Search bills, members, committees and pages...

MARGARET MARTIN

100 federal lobbying filings, 2023 to 2026.

MARGARET MARTIN is a registered lobbyist named on 100 federal lobbying filings, 2023 to 2026, reporting $4.4M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 they have filed under, by filings.

RegistrantFilingsReported
DLA PIPER LLP (US)100$4.4M

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202623$1.4M
202552$2.3M
202417$570K
20238$150K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues70
MEDMedical/Disease Research/Clinical Labs40
MMMMedicare/Medicaid27
PHAPharmacy27
TRDTrade (domestic/foreign)17
CPTCopyright/Patent/Trademark14
TAXTaxation/Internal Revenue Code10
BUDBudget/Appropriations8
DEFDefense7
TOBTobacco3

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 832EPIC Act of 202512
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.6
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…6
H.R. 1672Maintaining Investments in New Innovation Act5
H.R. 1262Mikaela Naylon Give Kids a Chance Act4
H.R. 946ORPHAN Cures Act4
S. 932Give Kids a Chance Act of 20254
H.R. 4121Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20262
S. 2256Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 20262
H.Con.Res. 14Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…1
H.R. 8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 20271
S.Con.Res. 7An original concurrent resolution setting forth the congressional budget for the United States Government for…1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICADLA PIPER LLP (US)2026 second_quarter$60KJul 20, 2026
NOVARTISDLA PIPER LLP (US)2026 second_quarter$60KJul 20, 2026
BIOGEN, INC.DLA PIPER LLP (US)2026 second_quarter$60KJul 20, 2026
PRELUDE CORPORATION (PRELUDEDX)DLA PIPER LLP (US)2026 second_quarter$70KJul 20, 2026
IRA WATCHDOGDLA PIPER LLP (US)2026 second_quarter$30KJul 20, 2026
COALITION FOR SMARTER REGULATION OF NICOTINEDLA PIPER LLP (US)2026 second_quarter$120KJul 20, 2026
BIONJ, INC.DLA PIPER LLP (US)2026 second_quarter$50KJul 17, 2026
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)DLA PIPER LLP (US)2026 second_quarter$60KJul 17, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONDLA PIPER LLP (US)2026 second_quarter$60KJul 17, 2026
REGENXBIO INC.DLA PIPER LLP (US)2026 second_quarter$60KJul 17, 2026
AVALYN PHARMA INC.DLA PIPER LLP (US)2026 second_quarter$60KJul 17, 2026
IRA WATCHDOGDLA PIPER LLP (US)2026 first_quarter$30KApr 20, 2026
NOVARTISDLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICADLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
BIOGEN, INC.DLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
AIDOC, INC.DLA PIPER LLP (US)2026 first_quarter$30KApr 20, 2026
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)DLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
BIOTECHNOLOGY INNOVATION ORGANIZATIONDLA PIPER LLP (US)2026 first_quarter$60KApr 20, 2026
PRELUDE CORPORATION (PRELUDEDX)DLA PIPER LLP (US)2026 first_quarter$70KApr 20, 2026
COALITION FOR SMARTER REGULATION OF NICOTINEDLA PIPER LLP (US)2026 first_quarter$120KApr 20, 2026
BIONJ, INC.DLA PIPER LLP (US)2026 first_quarter$50KApr 17, 2026
AVALYN PHARMA INC.DLA PIPER LLP (US)2026 first_quarter$60KApr 16, 2026
REGENXBIO INC.DLA PIPER LLP (US)2026 first_quarter$60KApr 16, 2026
AIDOC, INC.DLA PIPER LLP (US)2025 fourth_quarter$80KFeb 10, 2026
AIDOC, INC.DLA PIPER LLP (US)2025 fourth_quarterJan 30, 2026